Skip to results
Modify your search
NARROW
1-20 of 262
Authors: Michael Weller
Journal Article
ACCEPTED MANUSCRIPT
EDITOR'S CHOICE
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: a RANO review
Neuro-Oncology, noae032, https://doi.org/10.1093/neuonc/noae032
Published: 10 April 2024
Journal Article
ACCEPTED MANUSCRIPT
Marizomib for patients with newly diagnosed glioblastoma: a randomized phase 3 trial
Neuro-Oncology, noae053, https://doi.org/10.1093/neuonc/noae053
Published: 19 March 2024
Journal Article
Challenges, limitations, and pitfalls of PET and advanced MRI in patients with brain tumors: A report of the PET/RANO group Get access
Neuro-Oncology, noae049, https://doi.org/10.1093/neuonc/noae049
Published: 11 March 2024
Journal Article
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas Get access
Neuro-Oncology, noae037, https://doi.org/10.1093/neuonc/noae037
Published: 07 March 2024
Journal Article
Treatment-associated imaging changes in newly diagnosed MGMT promoter-methylated glioblastoma undergoing chemoradiation with or without cilengitide
Neuro-Oncology, noad247, https://doi.org/10.1093/neuonc/noad247
Published: 14 January 2024
Journal Article
Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group Get access
Neuro-Oncology, Volume 26, Issue 3, March 2024, Pages 584–586, https://doi.org/10.1093/neuonc/noad237
Published: 02 January 2024
Journal Article
CTNI-34. ZOTIRACICLIB (TG02) FOR NEWLY DIAGNOSED GLIOBLASTOMA IN THE ELDERLY OR FOR RECURRENT GLIOBLASTOMA: FINAL RESULTS OF THE EORTC 1608 STEAM TRIAL Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v81–v82, https://doi.org/10.1093/neuonc/noad179.0316
Published: 10 November 2023
Journal Article
EXTH-80. A SYSTEMIC COMPARISON OF CAR T CELLS, CAR NK CELLS AND CAR MACROPHAGES FOR GLIOMA TREATMENT Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v243, https://doi.org/10.1093/neuonc/noad179.0933
Published: 10 November 2023
Journal Article
EXTH-75. A MACROPHAGE-BASED DRUG DELIVERY PLATFORM FOR GLIOMA TREATMENT Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v241–v242, https://doi.org/10.1093/neuonc/noad179.0928
Published: 10 November 2023
Journal Article
BIOM-13. ASSOCIATION OF HAND-FOOT SKIN REACTIONS WITH SURVIVAL IN RECURRENT GLIOBLASTOMA PATIENTS TREATED WITH REGORAFENIB Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v6, https://doi.org/10.1093/neuonc/noad179.0024
Published: 10 November 2023
Journal Article
DDDR-24. SINGLE-CELL FUNCTIONAL TISSUE PROFILING IDENTIFIES PROMISING CANDIDATES FOR DRUG REPURPOSING AGAINST GLIOBLASTOMA Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v110–v111, https://doi.org/10.1093/neuonc/noad179.0418
Published: 10 November 2023
Journal Article
SURG-21. THE PROGNOSTIC ROLE OF RE-RESECTION FOR RECURRENT GLIOBLASTOMA: A REPORT OF THE RANO RESECT GROUP USING A NOVEL CLASSIFICATION FOR EXTENT OF RESECTION Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v266, https://doi.org/10.1093/neuonc/noad179.1020
Published: 10 November 2023
Journal Article
CTNI-58. UPDATED RESULTS AND MOLECULAR SUBGROUP ANALYSES FROM THE RANDOMIZED PHASE 3 MIRAGE TRIAL ON MARIZOMIB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v89, https://doi.org/10.1093/neuonc/noad179.0340
Published: 10 November 2023
Journal Article
PATH-19. PROGNOSTIC FACTORS, RESPONSE TO TREATMENT, AND OUTCOME OF PATIENTS WITH ISOCITRATE DEHYDROGENASE (IDH)-MUTANT ASTROCYTOMA, CNS WHO GRADE 4 Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v171, https://doi.org/10.1093/neuonc/noad179.0649
Published: 10 November 2023
Journal Article
CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v97–v98, https://doi.org/10.1093/neuonc/noad179.0366
Published: 10 November 2023
Journal Article
RTID-04. GLUGLIO - A PHASE IB/II RANDOMIZED DRUG REPURPOSING TRIAL OF GLUTAMATE SIGNALING INHIBITORS IN COMBINATION WITH CHEMORADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (NCT05664464) Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v259, https://doi.org/10.1093/neuonc/noad179.0995
Published: 10 November 2023
Journal Article
CTIM-22. PHASE I STUDY RESULTS OF THE ANTIBODY-CYTOKINE FUSION PROTEIN L19TNF IN COMBINATION WITH LOMUSTINE FOR PATIENTS WITH RECURRENT GLIOBLASTOMA REVEAL PROMISING SAFETY AND DURABLE TUMOR RESPONSES Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v66–v67, https://doi.org/10.1093/neuonc/noad179.0262
Published: 10 November 2023
Journal Article
EXTH-53. VEGFR2-SPECIFIC CAR-T CELLS SHOW IMPROVED TUMOR INFILTRATION IN SYNGENEIC MOUSE GLIOMA MODELS Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v236, https://doi.org/10.1093/neuonc/noad179.0906
Published: 10 November 2023
Journal Article
SURG-16. SAMPLING AND PROCESSING OF TUMOR TISSUE DURING RESECTION OF DIFFUSE INTRACRANIAL GLIOMA: INTERNATIONAL SURVEY AND RECOMMENDATIONS FOR STANDARDIZATION ON BEHALF OF FOUR RANO GROUPS Get access
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v264, https://doi.org/10.1093/neuonc/noad179.1015
Published: 10 November 2023
Journal Article
EDITOR'S CHOICE
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
Neuro-Oncology, Volume 26, Issue 1, January 2024, Pages 7–24, https://doi.org/10.1093/neuonc/noad154
Published: 12 September 2023
